A benzazepine derivative and selective HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED CHANNELS inhibitor that lowers the heart rate. It is used in the treatment of CHRONIC STABLE ANGINA in patients unable to take BETA-ADRENERGIC BLOCKERS, and in the treatment of HEART FAILURE.
Ivabradine has been studied across 14 research domains including ❤️ Cardiovascular, 😴 Sleep, 🔬 Inflammation, 🧠 Focus & Attention, 🏋️ Muscle & Hypertrophy. The primary research focus is ❤️ Cardiovascular with 52% of studies addressing this area.
The following compounds share molecular targets with Ivabradine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Ivabradine is generated deterministically from 293 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.